Healthcare Equipment and Supplies
Company Overview of Covidien International Finance S.A.
Covidien International Finance S.A. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. The company operates in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products, and Medical Supplies. The Medical Devices segment develops, manufactures, and sells endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, vascular devices, sharpsafety products, clinical care products, and other medical device products. The Imaging Solutions segment engages in the development, manufacture, and marketing of radiopharmaceuticals and contrast product...
17 Boulevard de la Grande Duchesse Charlotte
Founded in 2006
Key Executives for Covidien International Finance S.A.
Principal Executive Officer
Chief Executive Officer of Covidien Ltd
Senior Vice President of Tyco Healthcare Ltd and President of Medical Devices - Tyco Healthcare Ltd
Compensation as of Fiscal Year 2013.
Covidien International Finance S.A. Key Developments
Covidien International Finance S.A. Prices Underwritten Offering of $750 Million Aggregate Principal Amount of 2.950% Senior Notes Due 2023
May 17 13
Covidien plc announced that its subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $750 million aggregate principal amount of 2.950% senior notes due 2023. The company noted that the offering is expected to close on May 16, 2013. CIFSA intends to use the net proceeds of this offering to fund the repayment at maturity of all of its outstanding 1.875% senior notes due June 2013 and for general corporate purposes.
Covidien International Finance S.A. and Mallinckrodt International Financial Services Company Enter into Indenture with Deutsche Bank Trust Company Americas
Apr 12 13
On April 11, 2013, Mallinckrodt International Financial Services Company and Covidien International Finance S.A. entered into an indenture with Deutsche Bank Trust Company Americas, as trustee, relating to the issuance by MIFSA of $300,000,000 aggregate principal amount of 3.500% senior notes due 2018 and $600,000,000 aggregate principal amount of 4.750% senior notes due 2023. MIFSA will pay interest on the notes semi-annually in arrears on April 15 and October 15 of each year, commencing on October 15, 2013. The notes will be initially guaranteed by CIFSA on an unsecured and unsubordinated basis pursuant to the indenture. The CIFSA guarantee will terminate and be automatically and unconditionally released upon the satisfaction of certain conditions, including the completion of the Distribution. Mallinckrodt will guarantee the notes on an unsecured and unsubordinated basis upon the release of the CIFSA guarantee.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|